34 Best Canned Cocktails to Sip All Summer Long

Related Posts

20Jun

Secrets are hard to keep — but these 3 tech founders still chose stealth mode

Wasabi provides “hot storage,” which means it’s fast to write, low-cost and reliable cloud storage. Read more >> read more
11Apr

Meet Paul Gudonis, CEO of Myomo

Myomo is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Read... read more
05Sep

VC funding update: Boston startups and tech firms raised $1.3B in August

The VC summer slowdown may be real after all. Last month, Boston-area startups and tech firms raised a collective $1.3B—a... read more
19Dec

Visually Impaired 9-Year-Old Girl Sees Nutcracker Ballet for First Time with Help of eSight

Dell Technologies gave the gift of eSight to a visually impaired 9-year-old girl to view a performance of the 'Nutcracker'... read more
18Oct

Myomo, Inc. Launches Awareness Program for Veterans of the U.S. Armed Forces

MyoPro® for Veterans is Designed to Broaden MyoPro Accessibility to the Many Veterans Who May Benefit. Read more >> read more
10Apr

Early Stage by John Valentine/3Derm

Liz Asai, Co-Founder and CEO of Boston-based digital health startup 3Derm, joins Early Stage on the pod for Episode 10.... read more
14Apr

Pyramid Biosciences Expands Oncology Pipeline with In-Licensing of GQ1010, a Potential Best-in-class TROP2 Targeted Antibody Drug Conjugate (ADC), from GeneQuantum Healthcare

Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing transformative medicines for patients with cancer, today announced that... read more
13Feb

Windgap Medical: Injecting Simplicity Into Complex Drug Delivery

Injectable formulations are the fastest growing segment in the pharmaceutical industry. According to Precedence Research, the global injectable drug delivery... read more
20Nov

What Happens When Student Loan Payment Deferral Ends?

The Coronavirus Aid, Relief and Economic Security (CARES) Act included two provisions that were critical to helping Americans with student... read more
09Mar

Corbus Pharmaceuticals to Present Gene Expression Data from Recent Phase 2 Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation and Fibrosis Pathways

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious... read more